NM_031923.4:c.1325A>G
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_031923.4(TAF3):c.1325A>G(p.Asn442Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.59 in 1,613,814 control chromosomes in the GnomAD database, including 286,106 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N442Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_031923.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.538 AC: 81749AN: 151846Hom.: 23434 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.617 AC: 153701AN: 249222 AF XY: 0.611 show subpopulations
GnomAD4 exome AF: 0.596 AC: 870841AN: 1461848Hom.: 262668 Cov.: 77 AF XY: 0.595 AC XY: 432732AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.538 AC: 81780AN: 151966Hom.: 23438 Cov.: 31 AF XY: 0.547 AC XY: 40604AN XY: 74260 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at